Upcoming Events


Sep

Vascular Interventional Advances Annual Conference (VIVA) 2017

Sep 11 - 14, 2017

OVERVIEW

Vascular Interventional Advances Annual Conference (VIVA) is organized by Vascular Interventional Advances (VIVA) and would be held during Sep 11 - 14, 2017 at Wynn Las Vegas, Las Vegas, Nevada, United States of America.

Target Audience

The target audience for this CME activity is physicians who specialize in, among other areas, interventional cardiology, interventional radiology, vascular medicine, vascular surgery, cardiothoracic surgery, neurosurgery, podiatry and neuroradiology, as well as fellows, and allied health professionals (including nurses, vascular clinic staff, endovascular operating room staff, catheterization laboratory and angiography suite staff, nurse practitioners, vascular technologists, and physicians assistants).

Learning Objectives

At the conclusion of the course, the targeted learners should be able: • Understand the current indications, risks, complications, and outcome of medical, interventional, and surgical therapies for the treatment of peripheral arterial and venous diseases.

  • Incorporate advanced medical, endovascular, and surgical techniques and approaches into their own practices to improve the care and outcomes of patients.
  • Implement high quality guidelines based programs to improve the early identification and care of patients with non- cardiac vascular conditions.
  • Increase knowledge in critical decision-making and the comprehensive spectrum of care for patients with stroke and intracranial and extracranial carotid artery disease.
  • Improve the delivery of balanced and scientifically valid vascular care in accordance with expert opinion and practice.
  • Utilize strategies learned from the meeting including endovascular technologies, open surgical techniques, and hybrid approaches, for the treatment of patients with aortic diseases.
  • To gain and employ decision making and procedural strategies and techniques in patients with aortic and visceral aneurysms, dissections, deep venous thrombosis, venous insufficiency and pulmonary embolism.
  • Enhance the understanding and treatment skills across the entire range of venous physiology, anatomy, diseases, and management options.
  • Gain and then disseminate the most current knowledge base regarding vascular care as learned from experts in the field, exposure to live cases, and data from late-breaking clinical trials.

 

Learn More
Oct/Nov

TCT 2017

October 29 – Nov 2, 2017

OVERVIEW

Transcatheter Cardiovascular Therapeutics (TCT) is the world’s largest and most important educational meeting specializing in interventional cardiovascular medicine. For over 25 years, TCT has been the center of cutting-edge educational content, showcasing the latest advances in current therapies and clinical research. We hope that our longstanding commitment to lifesaving innovation translates into improved patient care.

Target Audience

This symposium is designed for interventional cardiologists, radiologists, clinical cardiologists, scientists, vascular medicine specialists, cardiac and vascular surgeons, nurse practitioners, cath lab technicians, and other healthcare professionals with a special interest in the field of interventional and vascular medicine.

Learning Objectives

By the end of the symposium, participants should be able to:

  • Apply the results from important clinical trials and evidence-based medicine to guide the management of patients with atherosclerosis and structural heart disease
  • Incorporate new interventional technologies and procedures into the care of patients with complex coronary and endovascular disease
  • Integrate advances in diagnostic evaluation and therapeutics into the treatment of patients with carotid and peripheral arterial disease
  • Implement appropriate pharmacologic management in the care of patients undergoing diagnostic arteriography and interventional therapies before, during, and after catheterization
  • Identify new interventional technologies and propose appropriate applications for patients with cardiovascular disease

 

Learn More